SCHEMBL7186152

SCHEMBL7186152

CCCCOc1ccc(C)c(OCCCC)c1C=CC(=O)c1ccc(O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.59
MAOB P27338 2/20 0.49
DPP4 P27487 1/20 0.44
PTPN1 P18031 1/20 0.44
CAPN1 P07384 1/20 0.44
LMNA P02545 2/20 0.44
ESR1 P03372 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
NR1H2 P55055 1/20 0.44
RNASEL Q05823 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 3/20 0.43
RAB9A P51151 2/20 0.43
P4HB P07237 1/20 0.43
CALM1 P0DP23 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184600 0.94 ABCG2 (0.57) ABCG2MAOBDPP4CAPN1LMNA
SCHEMBL7180664 0.89 ABCG2 (0.46) ABCG2MAOBDPP4PTPN1LMNA
SCHEMBL8469442 0.87 ABCG2 (0.56) ABCG2MAOBDPP4PTPN1CAPN1
SCHEMBL7185926 0.87 ABCG2 (0.45) ABCG2MAOBDPP4PTPN1LMNA
SCHEMBL7184886 0.87 ABCG2 (0.45) ABCG2MAOBDPP4PTPN1MAPT
SCHEMBL7187779 0.87 ABCG2 (0.56) ABCG2MAOBDPP4PTPN1CAPN1
SCHEMBL7189154 0.87 ABCG2 (0.47) ABCG2MAOBDPP4PTPN1BCHE
SCHEMBL7192459 0.86 ABCG2 (0.55) ABCG2MAOBCAPN1LMNACYP1A2
SCHEMBL7192456 0.86 ABCG2 (0.55) ABCG2MAOBCAPN1LMNACYP1A2
SCHEMBL7191167 0.86 ABCG2 (0.55) ABCG2MAOBDPP4PTPN1CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed